Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 581-588

  Lodish, Maya B ^a   Adams, Karen T ^a   Huynh, Thanh T ^a   Prodanov, Tamara ^a   Ling, Alex ^b   Chen, Clara ^b   Shusterman, Suzanne ^c   Jimenez, Camilo ^d   Merino, Maria ^e   Hughes, Marybeth ^e   Cradic, Kendall W ^f   Milosevic, Dragana ^f   Singh, Ravinder J ^f   Stratakis, Constantine A ^a   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; DNA; METADRENALIN; SUCCINATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SCREENING; CATECHOLAMINE BLOOD LEVEL; CHILD; CHROMAFFIN CELL; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROENDOCRINE TUMOR; ORGAN OF ZUCKERKANDL; PARAGANGLIOMA; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR DIAGNOSIS; URINE LEVEL; CHEMODECTOMA; CHROMAFFIN SYSTEM; ENDOCRINE TUMOR; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CHILD; ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARA-AORTIC BODIES; PARAGANGLIOMA, EXTRA-ADRENAL; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE;

EID: 77956199558     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0004     Document Type: Article

References (37)

1. Altergott R, Barbato A, Lawrence A, Paloyan E, Freeark RJ & Prinz RA 1985 Spectrum of catecholamine-secreting tumors of the organ of Zuckerkandl. Surgery 98 1121-1126. (Pubitemid 16104733)
2. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A et al. 2005 Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23 8812-8818.
3. Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J, Bertagna X, Schlumberger M, Jeunemaitre X, Gimenez-Roqueplo AP et al. 2007 Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 3822-3828. (Pubitemid 47607629)
4. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Skoldberg F, Husebye ES, Eng C & Maher ER 2001 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. American Journal of Human Genetics 69 49-54. (Pubitemid 32614017)
5. Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A et al. 2003 Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clinical Endocrinology 59 728-733.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN et al. 2000 Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287 848-851.
7. Benn DE & Robinson BG 2006 Genetic basis of phaeochromocytoma and paraganglioma. Best Practice & Research. Clinical Endocrinology & Metabolism 20 435-450.
8. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O et al. 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism 91 827-836.
9. Boedeker CC, Erlic Z, Richard S, Kontny U, Gimenez-Roqueplo AP, Cascon A, Robledo M, de Campos JM, van Nederveen FH, de Krijger RR et al. 2009 Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. Journal of Clinical Endocrinology and Metabolism 94 1938-1944.
10. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM & Pacak K 2006 High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. Journal of Clinical Endocrinology and Metabolism 91 4505-4509. (Pubitemid 44833431)
11. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V, Niccoli P, Gaillard D, Chabrier G, Chabolle F et al. 2009 The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. Journal of Clinical Endocrinology and Metabolism 94 2817-2827.
12. Carney JA & Stratakis CA 2002 Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. American Journal of Medical Genetics 108 132-139.
13. Donahue J, Sahani D, Tso L & Cusack JC Jr 2008 Extra-adrenal pheochromocytoma involving the organ of Zuckerkandl. Surgery 143 830-832.
14. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL & Kopin IJ 1986 Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clinical Chemistry 32 2030-2033.
15. Eng C, Kiuru M, Fernandez MJ & Aaltonen LA 2003 A role for mitochondrial enzymes in inherited neoplasia and beyond. Nature Reviews. Cancer 3 193-202.
16. Favier J, Plouin PF, Corvol P & Gasc JM 2002 Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. American Journal of Pathology 161 1235-1246.
17. Favier J, Briere JJ, Burnichon N, Riviere J, Vescovo L, Benit P, Giscos-Douriez I, De Reynies A, Bertherat J, Badoual C et al. 2009 The warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE 4 e7094.
18. Ghayee HK, Havekes B, Corssmit EP, Eisenhofer G, Hammes SR, Ahmad Z, Tessnow A, Lazurova I, Adams KT, Fojo AT et al. 2009 Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior. Endocrine-Related Cancer 16 291-299.
19. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF & Jeunemaitre X 2003 Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Research 63 5615-5621.
20. Gimenez-Roqueplo AP, Burnichon N, Amar L, Favier J, Jeunemaitre X & Plouin PF 2008 Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. Clinical and Experimental Pharmacology and Physiology 35 376-379. (Pubitemid 351326766)
21. Gottlieb E & Tomlinson IP 2005 Mitochondrial tumour suppressors: a genetic and biochemical update. Nature Reviews. Cancer 5 857-866. (Pubitemid 41746030)
22. Havekes B, Corssmit EP, Jansen JC, van der Mey AG, Vriends AH & Romijn JA 2007 Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. Journal of Clinical Endocrinology and Metabolism 92 1245-1248. (Pubitemid 46556393)
23. Hollinshead WH 1940 Chromaffin tissue and paraganglia. Quarterly Review of Biology 15 156-171.
24. Jimenez C, Cote G, Arnold A & Gagel RF 2006 Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? Journal of Clinical Endocrinology and Metabolism 91 2851-2858.
25. Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, Feunteun J, Pouyssegur J, Richard S & Gardie B 2008 PHD2 mutation and congenital erythrocytosis with paraganglioma. New England Journal of Medicine 359 2685-2692.
26. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS & Kopin IJ 1993 Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clinical Chemistry 39 97-103. (Pubitemid 23034964)
27. Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC & Milliner DS 2007 Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. Journal of the American Society of Nephrology 18 1905-1914.
28. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466.
29. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA et al. 2004 Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 292 943-951.
30. Ober WB 1983 Emil Zuckerkandl and his delightful little organ. Pathology Annual 18 103-119.
31. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez- Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM & Tischler AS 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature Clinical Practice. Endocrinology & Metabolism 3 92-102. (Pubitemid 46146962)
32. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G et al. 2008 Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. European Journal of Human Genetics 16 79-88.
33. Prodanov T, Havekes B, Nathanson KL, Adams KT & Pacak K 2009 Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening? Pediatric Nephrology 24 1239-1242.
34. Solis DC, Burnichon N, Timmers HJ, Raygada MJ, Kozupa A, Merino MJ, Makey D, Adams KT, Venisse A, Gimenez-Roqueplo AP et al. 2009 Penetrance and clinical consequences of a gross SDHB deletion in a large family. Clinical Genetics 75 354-363.
35. Subramanian A & Maker VK 2006 Organs of Zuckerkandl: their surgical significance and a review of a century of literature. American Journal of Surgery 192 224-234. (Pubitemid 44066300)
36. Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW & Pacak K 2007 Clinical presentations, biochemical phenotypes, and genotype- phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. Journal of Clinical Endocrinology and Metabolism 92 779-786. (Pubitemid 46465640)
37. Timmers HJ, Pacak K, Bertherat J, Lenders JW, Duet M, Eisenhofer G, Stratakis CA, Niccoli-Sire P, Tran BH, Burnichon N et al. 2008 Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clinical Endocrinology 68 561-566. (Pubitemid 351388709)